Effekte von Leitlinien

Archiv für Juni 2009

Do modifications of the American Heart Association guidelines improve survival of patients with out-of-hospital cardiac arrest?

Montag, 08. Juni 2009

< ![CDATA[

Do modifications of the American Heart Association guidelines improve survival of patients with out-of-hospital cardiac arrest?

Circulation. 2009 May 19;119(19):2542-4

Authors: Ewy GA

PMID: 19451362 [PubMed - in process]

]]>

ACP Journal Club. Implementation of an evidence-based feeding guideline did not reduce mortality in intensive care units.

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

ACP Journal Club. Implementation of an evidence-based feeding guideline did not reduce mortality in intensive care units.

Ann Intern Med. 2009 May 19;150(10):JC5-13

Authors: Ferri M, Adhikari N

PMID: 19451569 [PubMed]

]]>

Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?

Ann Intern Med. 2009 May 19;150(10):717-24

Authors: O’Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB

Angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists are recommended for patients with chronic kidney disease because these drugs can slow disease progression. Older adults account for a large and growing number of patients with chronic kidney disease. The authors evaluated the relevance to adults older than 70 years of the evidence base for major U.S. practice guidelines for the use of these agents in chronic kidney disease. The authors first examined the representation of older adults in randomized trials that underpin these guidelines, then compared the characteristics of participants in these trials with those of a representative sample of older adults with chronic kidney disease in the general population. The authors found that current guidelines for the use of angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease are based on evidence with limited relevance to most persons older than 70 years with this condition.

PMID: 19451579 [PubMed - indexed for MEDLINE]

]]>

Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons?

Montag, 08. Juni 2009

< ![CDATA[

Does evidence support renin-angiotensin system blockade for slowing nephropathy progression in elderly persons?

Ann Intern Med. 2009 May 19;150(10):731-3

Authors: Sarafidis PA, Bakris GL

PMID: 19451583 [PubMed - indexed for MEDLINE]

]]>

Related Articles

ACMG practice guideline: Genetic evaluation of short stature.

Montag, 08. Juni 2009

< ![CDATA[

ACMG practice guideline: Genetic evaluation of short stature.

Genet Med. 2009 May 14;

Authors: Seaver LH, Irons M,

Short stature is a common indication for genetic evaluation. The differential diagnosis is broad and includes both pathologic causes of short stature and nonpathologic causes. The purpose of genetic evaluation for short stature is to provide accurate diagnosis for medical management and to provide prognosis and recurrence risk counseling for the patient and family. There is no evidence-based data to guide the geneticist in an efficient, cost-effective approach to the evaluation of a patient with short stature. This guideline provides a rubric for the evaluation of short stature evaluation and summarizes common diagnoses and clinical testing available.

PMID: 19451827 [PubMed - as supplied by publisher]

]]>

Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization.

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization.

J Gen Intern Med. 2009 May 20;

Authors: Levy DE, Garber JE, Shields AE

BACKGROUND: BRCA1/2 testing is one of the most well-established genetic tests to predict cancer risk. Guidelines are available to help clinicians determine who will benefit most from testing. OBJECTIVE: To identify women at high risk of hereditary breast and ovarian cancer and estimate their awareness of and experience with genetic testing for cancer risk. DESIGN: Analyses of the 2000 and 2005 National Health Interview Surveys. PARTICIPANTS: Women with no personal history of breast or ovarian cancer (n = 35,116). MEASUREMENTS: Risk of hereditary breast or ovarian cancer based on self-reported family history of cancer and national guidelines; self-reported awareness of genetic testing for cancer risk; discussion of genetic testing for cancer risk with a health professional; having undergone genetic testing for breast/ovarian cancer risk. RESULTS: Using guideline criteria, 0.96% of women were identified as being at high risk of hereditary breast and ovarian cancer. Among high-risk women, 54.04% were aware of genetic testing for cancer risk, 10.39% had discussed genetic testing with a health professional, and 1.41% had undergone testing for breast/ovarian cancer risk. Adjusting for survey year, high-risk women were more likely than average-risk women to have heard of genetic testing for cancer risk (RR, 1.3, 95% CI 1.2-1.4), to have discussed genetic testing with a health professional (RR 5.2, 95% CI 3.6-7.4), and to have undergone genetic testing for breast/ovarian cancer risk (RR 6.8, 95% CI 2.6-18.0). CONCLUSIONS: We find low provision of guideline-recommended advice to women for whom testing may be appropriate and of significant clinical benefit.

PMID: 19455369 [PubMed - as supplied by publisher]

]]>

Why are Guidelines More Irrational than Metaanalyses?

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

Why are Guidelines More Irrational than Metaanalyses?

Psychiatr Prax. 2009 May 19;

Authors: Steinert T

PMID: 19455484 [PubMed - as supplied by publisher]

]]>

Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia.

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia.

J Am Geriatr Soc. 2009 Jun;57(6):1030-5

Authors: El Solh AA, Akinnusi ME, Alfarah Z, Patel A

OBJECTIVES: To compare the 2003 community-acquired pneumonia (CAP) guideline and the 2005 healthcare-associated pneumonia (HCAP) guideline on time to clinical stability, length of hospital stay, and mortality in nursing home patients hospitalized for pneumonia. DESIGN: Retrospective study. SETTING: Three tertiary-care hospitals. PARTICIPANTS: Three hundred thirty-four nursing home patients. MEASUREMENTS: Patients were classified according to the antibiotic regimens they received based on the 2003 CAP guideline or the 2005 HCAP guideline. Time to clinical stability, time to switch therapy, and mortality were evaluated in an intention-to-treat analysis. A multivariate survival model using propensity analysis was used to adjust for heterogeneity between the two groups. RESULTS: Of the 334 patients, 258 (77%) were treated according to the 2003 HCAP guideline. Time to clinical stability did not differ between those treated according to the 2003 CAP or the 2005 HCAP guidelines. Only the Pneumonia Severity Index (P=.006) and multilobar involvement (P=.005) were significantly associated with delay in achieving clinical stability. Adjusted in-hospital and 30-day mortality were comparable in both cohorts (odds ratio (OR)=0.87, 95% confidence interval (CI)=0.49-1.34, and OR=0.79, 95% CI=0.42-1.31, respectively), although time to switch therapy and length of stay were longer for those treated according to the 2005 HCAP guideline. CONCLUSION: In hospitalized nursing home patients with pneumonia, treatment with an antibiotic regimen according to the 2003 CAP guideline achieved comparable time to clinical stability and in-hospital and 30-day mortality with a regimen based on the 2005 HCAP guideline.

PMID: 19460091 [PubMed - in process]

]]>

ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients.

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients.

Clin Nutr. 2009 May 20;

Authors: Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, Jeppesen P, Moreno J, Hébuterne X, Pertkiewicz M, Mühlebach S, Shenkin A, Van Gossum A

Home parenteral nutrition (HPN) was introduced as a treatment modality in the early 1970s primarily for the treatment of chronic intestinal failure in patients with benign disease. The relatively low morbidity and mortality associated with HPN has encouraged its widespread use in western countries. Thus there is huge clinical experience, but there are still few controlled clinical studies of treatment effects and management of complications. The purpose of these guidelines is to highlight areas of good practice and promote the use of standardized treatment protocols between centers. The guidelines may serve as a framework for development of policies and procedures.

PMID: 19464089 [PubMed - as supplied by publisher]

]]>

Adherence to the French Programme National Nutrition Santé Guideline Score is associated with better nutrient intake and nutritional status.

Montag, 08. Juni 2009

< ![CDATA[

Related Articles

Adherence to the French Programme National Nutrition Santé Guideline Score is associated with better nutrient intake and nutritional status.

J Am Diet Assoc. 2009 Jun;109(6):1031-41

Authors: Estaquio C, Kesse-Guyot E, Deschamps V, Bertrais S, Dauchet L, Galan P, Hercberg S, Castetbon K

BACKGROUND: The Nutrition and Health Program (Programme National Nutrition Santé), which has been carried out in France since 2001, includes diet and physical activity recommendations that are being widely disseminated to the general population. OBJECTIVES: To develop a score based on adherence to these recommendations and retrospectively estimated its association with demographic and behavior factors, nutrient intake, and serum biomarkers. The Programme National Nutrition Santé Guideline Score (PNNS-GS) includes 13 components. Scoring and cut-off values were determined using information provided by national guidelines. At least one point was attributed when the behavior reported was in accordance with the recommendation. DESIGN/SUBJECTS: Adults participating in the SU.VI.MAX study with a minimum of three 24-hour dietary records were included in our analysis (n=5,500). STATISTICAL ANALYSIS: Data were analyzed by sex, and sex-specific quartiles of scores were estimated. Multiple logistic regression models adjusted for social and demographic variables were used to estimate the odds ratios for having a relatively high score (quartile 4 vs others). Multivariate linear regression models were used to examine associations of nutrient intake or biomarkers with PNNS-GS quartiles. When applicable, we included a linear contrast to test for trend. RESULTS: The authors found statistical associations between the top PNNS-GS quartile and older age, higher occupational categories, nonsmoking status, and normal body mass (P < or = 0.05). Higher PNNS-GS was also associated with lower intake of energy, cholesterol, and added simple sugars, and higher intake of various protective micronutrients. In addition, higher levels of serum beta-carotene and vitamin C were positively associated with increasing quartiles of PNNS-GS. CONCLUSIONS: This score is a useful tool for monitoring compliance with the French recommendations.

PMID: 19465185 [PubMed - in process]

]]>

Related Articles